Liver cancer wars: plant-derived polyphenols strike back

Area of Science:

• Oncology
• Pharmacology
• Natural Products Chemistry

Background:

• Liver cancer is a major global health issue, often linked to chronic inflammation and cirrhosis.
• Current treatments like surgery, radiation, and chemotherapy have limitations, highlighting the need for novel therapeutic strategies.
• Plant-derived polyphenols, known for their diverse biological activities and low toxicity, are emerging as potential candidates for liver cancer treatment.

Purpose of the Study:

• To review the role of plant-derived polyphenols in combating hepatic carcinogenesis.
• To explore the molecular mechanisms by which polyphenols exert anti-liver cancer effects.
• To discuss the potential and challenges of translating polyphenol-based therapies into clinical practice.

Main Methods:

• Literature review focusing on hepatic carcinogenesis and polyphenol mechanisms.
• Analysis of experimental data on chemopreventive and chemotherapeutic properties of plant-derived polyphenols.
• Synthesis of information on polyphenol-mediated modulation of cellular pathways involved in liver cancer.

Main Results:

• Plant-derived polyphenols can impact multiple signaling pathways crucial for liver cancer initiation, progression, and metastasis.
• Specific anti-liver cancer mechanisms include modulation of cell proliferation, apoptosis, autophagy, angiogenesis, oxidative stress, and inflammation.
• Numerous polyphenols demonstrate chemopreventive and chemotherapeutic potential in preclinical studies.

Conclusions:

• Plant-derived polyphenols offer a promising avenue for developing novel liver cancer therapies.
• Understanding their molecular mechanisms is key to optimizing their therapeutic application.
• Bridging the gap between preclinical findings and clinical success presents both opportunities and challenges for polyphenol-based drug development.